Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Korea.
Cancer Res Treat. 2021 Jan;53(1):25-31. doi: 10.4143/crt.2020.235. Epub 2020 Aug 31.
This study aimed to validate the Sheffield Profile for Assessment and Referral to Care (SPARC) as an effective tool for screening palliative care needs among Korean cancer patients.
The English version of the SPARC was translated by four Korean oncologists and reconciled by a Korean language specialist and a medical oncologist fluent in English. After the first version of the Korean SPARC (K-SPARC) was developed, back-translation into English was performed by a professional translator and bilingual oncologist. The back-translated version was reviewed by the original author (S.H.A.), and modifications were made (ver. 2). The second version of the K-SPARC was tested against other questionnaires, including the Functional Assessment of Cancer Therapy-General (FACT-G) and the Edmonton Symptom Assessment System (ESAS).
Thirty patients were enrolled in the pilot trial. Fifteen were male, and the median age was 64.5 years. Six patients had an Eastern Cooperative Oncology Group performance status of 2 or more. All patients except one were receiving chemotherapy. Regarding internal consistency, the Cronbach's α scores for physical symptoms, psychological issues, religious and spiritual issues, independency and activity, family and social issues, and treatment issues were 0.812, 0.804, 0.589, 0.843, 0.754, and 0.822, respectively. The correlation coefficients between the SPARC and FACT-G were 0.479 (p=0.007) for the physical domain and -0.130 (p=0.493) for the social domain.
This pilot study indicates that the K-SPARC could be a reliable tool to screen for palliative care needs among Korean cancer patients. A further study to validate our findings is ongoing.
本研究旨在验证谢菲尔德评估和转介至关怀（SPARC）量表作为一种有效的工具，用于筛查韩国癌症患者的姑息治疗需求。
由四位韩国肿瘤学家翻译 SPARC 的英文版本，再由一位韩国语言专家和一位英语流利的肿瘤内科医生进行协调。第一版韩国 SPARC（K-SPARC）制定后，由专业翻译和双语肿瘤学家进行英文回译。回译版本由原作者（S.H.A.）审查，并进行修改（版本 2）。对 K-SPARC 的第二版进行了其他问卷的测试，包括癌症治疗功能评估一般量表（FACT-G）和埃德蒙顿症状评估系统（ESAS）。
该试点研究共纳入 30 名患者。其中 15 名为男性，中位年龄为 64.5 岁。6 名患者的东部肿瘤协作组表现状态为 2 或更高。除 1 名患者外，所有患者均接受化疗。关于内部一致性，身体症状、心理问题、宗教和精神问题、独立性和活动、家庭和社会问题以及治疗问题的 Cronbach's α 评分分别为 0.812、0.804、0.589、0.843、0.754 和 0.822。SPARC 与 FACT-G 的相关系数在身体领域为 0.479（p=0.007），在社会领域为-0.130（p=0.493）。
这项试点研究表明，K-SPARC 可能是一种可靠的工具，用于筛查韩国癌症患者的姑息治疗需求。一项验证我们研究结果的进一步研究正在进行中。
